Doctor of Podiatric Medicine Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Palwasha Ahmed

Podiatrist Berkeley, CA Doctor of Podiatric Medicine

NPI 1669051116 CMS profile 10179605

3000 Colby St Ste 107, Berkeley, CA 94705

Open in the dashboard

General payments

$9,766

108 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Palwasha Ahmed of Berkeley, CA is reported in the CMS Open Payments database as having received $9,766 across 108 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,979 27
2024 General $3,177 37
2023 General $1,639 26
2022 General $2,783 16
2021 General $188 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Palwasha Ahmed
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Palwasha Ahmed were reported at $1,979. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Palwasha Ahmed Podiatrist median Middle half National median
2019 $0 $196 $72–$601 $163
2020 $0 $118 $38–$335 $114
2021 $188 $169 $57–$573 $132
2022 $2,783 $220 $74–$782 $149
2023 $1,639 $208 $71–$635 $160
2024 $3,177 $237 $87–$681 $164
2025 $1,979 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Stryker Corporation $3,606 46 payments
  2. Medwest Associates $1,229 3 payments
  3. Treace Medical Concepts, Inc. $1,215 6 payments
  4. Integra LifeSciences Corporation $557 8 payments
  5. Acera Surgical, Inc. $414 3 payments
  6. Orthofix Medical, Inc. $367 5 payments
  7. Alafair Biosciences,Inc. $358 3 payments
  8. DePuy Synthes Sales Inc. $306 7 payments
  9. Horizon Therapeutics plc $289 2 payments
  10. International Life Sciences $226 1 payment
  11. Other $1,198 24 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,838 100 payments
  2. Travel and Lodging $1,728 7 payments
  3. Education $1,200 1 payment
Products named General payments · program years 2021–2025
  1. INFINITY ADAPTIS $1,041 9 payments
  2. LAPIPLASTY SYSTEM 1 $888 2 payments
  3. Integra Recon-Skin And Wound $557 8 payments
  4. Integra Recon-Skin And Wound $557 8 payments
  5. PRIMATRIX $557 8 payments
  6. Integra Recon-Skin And Wound $557 8 payments
  7. INTEGRA DERMAL REGENERATION TEMPLATE $557 8 payments
  8. INFINITY $529 4 payments
  9. INBONE $433 7 payments
  10. Restrata Wound Matrix $414 3 payments
  11. Other $5,137 73 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$28,298

Medicare's payments for the services billed

Medicare patients

221

Average age 77

Services billed

466

124 women, 97 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Diabetes 43%
Chronic kidney disease 32%
Ischemic heart disease 21%
Depression 19%
Cancer 18%
Osteoporosis 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

108 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record